Minhtran Ngo

Immunology and Microbiology · Life Sciences

9h-index1.5kcitations24works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(17), CAR-T cell therapy research(16), Immunotherapy and Immune Responses(9), Virus-based gene therapy research(9), Viral-associated cancers and disorders(4)

Publications24 total

Supplement methodology from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Supplementary figures 1-2 from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Supplement methodology from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Data from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Supplementary figures 1-2 from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Data from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Supplementary figure legend from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Supplementary figure legend from Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2023Open Access
Broadly-specific Cytotoxic T Cells Targeting Multiple HIV Antigens Are Expanded From HIV+ Patients: Implications for Immunotherapy
UNC Libraries·2020Open Access
Identification of protective T-cell antigens for smallpox vaccines
Cytotherapy·2020· 15 citedOpen Access
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
Clinical Cancer Research·2017· 103 citedOpen Access
Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma
Journal for ImmunoTherapy of Cancer·2015Open Access
722. Overcoming EBV Tumor Specific T-Cell Anergy in Rapidly-Generated EBVST-Cells for Adoptive Transfer Therapy
Molecular Therapy·2015Open Access
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
Molecular Therapy·2014· 156 citedOpen Access
Broadly-specific Cytotoxic T Cells Targeting Multiple HIV Antigens Are Expanded From HIV+ Patients: Implications for Immunotherapy
Molecular Therapy·2014· 47 citedOpen Access
Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity
Journal of Immunotherapy·2014· 61 citedOpen Access
An antigen presenting complex for the generation of broad-specificity effector T lymphocytes for the treatment of EBV-associated malignancies
Cytotherapy·2013
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Nature Medicine·2013· 754 citedOpen Access
Abstract IA21: Using viruses to advance T cell therapy for malignancy.
Cancer Research·2013
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Cytotherapy·2012· 202 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Cliona M. Rooney(23), Ann M. Leen(16), Jun Ando(15), Gianpietro Dotti(10), Birju Mehta(10), Miyuki Tanaka(9), Haruko Tashiro(9), Bilal Omer(9), Natasha Lapteva(9), Paul R. Kinchington(9), Claudia Rössig(9), Helen E. Heslop(7), Catherine M. Bollard(7), Natalia Lapteva(4), Juan F. Vera(4), Caroline J. Breitbach(3), Anne Moon(3), David H. Kirn(3), Stephen Gottschalk(3), James M. Burke(2)